Investor Overview

Home › Investor Overview

As of May 2013, Angiotech will no longer be a voluntary filer of its financial information with the U.S. Securities and Exchange Commission, and going forward Angiotech will be a fully private company. If you are a current Angiotech shareholder and have questions, or you would like to receive our most recent quarterly financial information, please email ir@angio.com with your name and the name of your agent, if applicable. Please be advised that we will ONLY send information to current shareholders, and only to the address as provided on the current share registry at the time of the mailing.

This information is intended for investors. Please read our website's Terms of Use.

Welcome to Angiotech's Investor Relations section. Use the navigation menu on the left to find up-to-date corporate financial information. Some other helpful links include:

Important Financial Release Dates

Q1 : Tuesday, May 15, 2012
Q2 : Wednesday, August 15, 2012
Q3 : Thursday, November 15, 2012
Q4 and Year End : TBA

Investor Relations Contacts

Investors, security analysts and representatives of portfolio management firms may contact:

tel: (604) 221-7933
email: ir@angio.com.

Investor Overview

Investor Relations Contacts

Investors

Quick Links